Dashamlav AI Labs

Dashamlav AI Labs Transforming Oncology Care through AI

On 13 November 2026, India's DPDP Rules reach their 12-month mark and consent-manager registration opens. From 13 May 20...
05/11/2026

On 13 November 2026, India's DPDP Rules reach their 12-month mark and consent-manager registration opens. From 13 May 2027, most obligations apply to hospitals as data fiduciaries: clear notices, security safeguards, breach reporting to the Data Protection Board, and responses to patient rights requests within 90 days. Hospitals also remain accountable for the vendors that handle patient data.

In oncology, where one patient's record spans many departments and apps, that makes vendor security a leadership decision.

Dashamlav's One Oncology Ecosystem of OncFlow®, MedCompass® and PulseDash® is built on FHIR and certified to ISO/IEC 27001:2022 and ISO 27799:2025.

Plan your oncology data roadmap: https://dashamlavlabs.ai

From 9 November 2026, NPPA's 30% trade-margin cap on 137 anti-cancer drugs takes effect, with revised MRPs already publi...
04/11/2026

From 9 November 2026, NPPA's 30% trade-margin cap on 137 anti-cancer drugs takes effect, with revised MRPs already published for 543 brands. As therapy becomes more affordable, oncology teams should expect more patients starting and continuing treatment, and more monitoring between visits.

Dashamlav's One Oncology Ecosystem is built for that load. OncFlow® supports oncologists with staging, case summaries and guideline-concordant care plans. PulseDash® holds the in-between, with CTCAE-aligned symptom grading, care-team alerts and reminders in 6+ languages. Clinicians make every decision.

Used by 35+ customers and 170+ clinicians.

Ahead of National Cancer Awareness Day on 7 November, see how the ecosystem works: http://dashamlavlabs.ai

A milestone in our journey.PulseDash® and MedCompass® are now registered trademarks of Dashamlav AI Labs.For us, this is...
17/10/2026

A milestone in our journey.

PulseDash® and MedCompass® are now registered trademarks of Dashamlav AI Labs.

For us, this is more than a legal formality. It marks how far both products have matured, from ideas built alongside clinicians and patients into established parts of how we support cancer care.

It also brings our product family together under one portfolio:

OncFlow® supports oncologists in the clinic with AI-powered clinical decision support.
PulseDash® helps patients between visits, capturing symptoms and keeping them connected to their care team.
MedCompass® puts clinical insight on the physician’s phone.

All three run on one platform, serving two journeys. Care providers get insights, and patients get confidence.

Our thanks go to the clinicians, hospital partners and patients who have shaped these products with us. We remain committed to advancing AI-powered oncology, empowering clinicians and supporting patients.

In cancer care, a doctor’s most valuable resource is time.Time to listen.Time to think.Time to explain.Time to care.That...
08/10/2026

In cancer care, a doctor’s most valuable resource is time.
Time to listen.
Time to think.
Time to explain.
Time to care.

That is why Dashamlav was proud to participate in the — connecting with oncologists, healthcare professionals and cancer survivors around a purpose that drives us.

How can technology reduce the administrative burden on doctors, so they can spend more time with their patients?

Through OncFlow, we are using AI to simplify and automate critical oncology workflows — reducing the time doctors spend on documentation, information gathering and routine administrative tasks.

The goal is simple: give the oncologist back the time to be an oncologist.
And our journey doesn't stop at the consultation room.

Through solutions such as PulseDash, we are working to keep patients connected with their care teams beyond hospital visits — because continuity of care and survivorship have a direct bearing on better patient outcomes.

This is at the heart of our mission:
Reduce the burden on care providers. Strengthen the patient connection. Improve outcomes. Enable better survivorship.

Nepal was another meaningful step in that journey — listening, learning and building connections across the oncology community.

If you believe technology should give doctors more time to care and patients a better chance at better outcomes, we would love to hear from you.

Hearty thats to Dr. Sudip Shrestha for providing us platform and believing in our mission and Mr. Diwakar Rijal for providing the market direction and pulling strings for connects.

04/02/2026

Three years. Three principles.

Supporting 150+ clinicians and 14,000+ patients with AI-driven oncology workflow automation taught us what physicians need most.

1. Clarity over complexity. Oncologists don't have time for fragmented tools. We deliver automated TNM staging, instant case summaries, pathology report analysis, and guideline-concordant treatment planning as a single, coherent workflow. Our product narrative on the redesigned website now reflects this integrated approach.

2. Evidence precedes adoption. In oncology, trust comes from peer-reviewed validation, published research, and measurable clinical outcomes. We've published ours.

3. Security architecture, not security features. Patient confidentiality isn't negotiable. PII minimization, auditability, encryption, access controls, and data lifecycle management are built into every workflow from day one - not added as afterthoughts.

Today on World Cancer Day, we're launching our redesigned website: www.dashamlavlabs.ai

What you'll find:

- A unified platform narrative showing how workflow automation works as a cohesive clinical solution

- Published research validating AI-driven staging accuracy

- Case studies from breast cancer radiotherapy protocol optimization to measurable efficiency gains in radiation oncology operations

- Security architecture that protects patient data at every step

We remain committed to transparency - in our research, our clinical partnerships, and our service to the oncology community.

www.dashamlavlabs.ai

✨ Stepping into 2026 with Clarity and Conviction ✨At Dashamlav AI Labs, we believe healthcare AI must do one thing excep...
31/12/2025

✨ Stepping into 2026 with Clarity and Conviction ✨

At Dashamlav AI Labs, we believe healthcare AI must do one thing exceptionally well:
Support clinicians make better decisions—faster, simpler, and with confidence.

As we enter the new year, our focus remains clear:
✔️ Clinician-first design
✔️ Meaningful oncology insights
✔️ Responsible, real-world AI impact

Grateful to our clinicians, partners, and team for the trust and momentum.

Here’s to a year of better decisions and better outcomes.

🌟 Happy New Year from Dashamlav AI Labs 🌟

Proud to welcome our second international customer—Dashamlav is officially scaling beyond borders.                      ...
23/12/2025

Proud to welcome our second international customer—Dashamlav is officially scaling beyond borders.


22/12/2025

Oncologists navigate critical challenges: burnout, data overload, and complex decision-making.
Dashamlav is reimagining oncology by humanizing care through advanced AI. Our platform enhances treatment plans while streamlining clinical workflows.
Empower your team with data-driven insights to reduce cognitive load and improve patient outcomes. Comment “Demo” to schedule a session or visit dashamlavlabs.ai to learn more.


Address

Wanwadi
Pune
411040

Alerts

Be the first to know and let us send you an email when Dashamlav AI Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Dashamlav AI Labs:

Shortcuts

Share

Nearby computer & electronics services